GENIL.E.IS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: April 28, 2026

Report Source: 2025 Annual Report

Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS

Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS. Stock Analysis GENIL.E.IS

Turkey Health Care Small Cap Report:
Gen Ilaç ve Saglik Ürünleri Sanayi ve Ticaret AS operates as a supplier of orphan drugs. The firm operates in the fields of manufacturing all kinds of pharmaceuticals for human use and health products, trading, import and export. Gen Ilac manufactures products used in the treatment of rare diseases and disorders in neurology, endocrinology, nephrology, oncology, hematology and pediatric branches. The firm has approximately 500 employees working in its production facilities on a closed area of 15,000 square meters, established on an area of approximately 43,000 square meters in Ankara ASO 2nd and 3rd Organized Industrial Zone. Entity has 5 offices abroad: Germany, Russia, Kazakhstan, Uzbekistan and Azerbaijan.
Read More

Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL.E.IS) Chart

Key Statistics of Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL.E.IS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

TRY8.63TRY9.03

Today's Open

TRY9.30

Volume

30.49M

P/E Ratio (TTM)

51.16

52 Week Range

TRY7.12TRY224.00

Market Cap

36.15B

Avg. Volume

32.99M

Dividend Yield

0.53%

Financial Metrics & Statements of Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL.E.IS)

FAQ's for Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL.E.IS)

  • According to Musaffa’s Shariah screening methodology, Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL.E.IS) is currently classified as HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.